Bone has the ability to regenerate as part of the healing process after an injury, as well as during skeletal development and ongoing remodelling throughout adulthood. In order to optimize skeletal repair and restore skeletal function, bone regeneration is composed of a well-orchestrated series of biological events of bone induction and conduction, involving a variety of cell types and intracellular and extracellular molecular-signaling pathways, with a definable temporal and spatial sequence, involving a number of cell types and intracellular and extracellular molecular-signalling pathways. The most common form of bone regeneration in the clinical context is fracture healing, which mimics the normal embryonic skeletogenesis pathway, including intramembranous and endochondral ossification. Bone tissue engineering (BTE) has been around for about three decades. The BTE discipline has witnessed enormous growth in interest and progress over the years, with an exponentially increasing number of papers and reviews published. BTE is a field that focuses on alternative therapy methods that, in theory, will eliminate the previously mentioned difficulties with currently employed clinical therapies (i.e., donor site morbidity, limited availability, immune rejection, and pathogen transfer). To attain the ultimate aim of developing bone grafts that improve bone repair and regeneration, BTE requires the collaboration of scientists, engineers, and surgeons.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States